ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+12.61%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$935M
AUM Growth
+$935M
(+8.4%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
41.74%
Holding
114
New
20
Increased
25
Reduced
19
Closed
21
Top Buys
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$15.9M |
| 2 |
Amazon
AMZN
|
$13.4M |
| 3 |
GE Vernova
GEV
|
$11M |
| 4 |
Enphase Energy
ENPH
|
$10.7M |
| 5 |
CAVA Group
CAVA
|
$10.5M |
Top Sells
| 1 |
Apple
AAPL
|
$12.6M |
| 2 |
Merck
MRK
|
$10.3M |
| 3 |
Arm
ARM
|
$9.87M |
| 4 |
HubSpot
HUBS
|
$9.73M |
| 5 |
Novo Nordisk
NVO
|
$9.71M |
Sector Composition
| 1 | Healthcare | 28.83% |
| 2 | Technology | 26.63% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Industrials | 12.17% |
| 5 | Communication Services | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ferguson
FERG
$46.4B
| $5.82M | 0.6% |
29,300
| – | – |
|
|
BECN
52
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $5.7M | 0.58% |
66,000
+9,500
| +17% | +$821K |
|
53
Core & Main
CNM
$12.3B
| $5.55M | 0.57% |
125,000
-40,000
| -24% | -$1.78M |
|
54
BBB Foods
TBBB
$3.09B
| $5.46M | 0.56% |
182,000
-43,000
| -19% | -$1.29M |
|
55
Axsome Therapeutics
AXSM
$6.05B
| $5.12M | 0.53% |
57,000
+8,000
| +16% | +$719K |
|
56
Advanced Micro Devices
AMD
$264B
| $5.09M | 0.52% |
+31,000
| New | +$5.09M |
|
57
Xenon Pharmaceuticals
XENE
$2.98B
| $4.96M | 0.51% |
126,000
+2,000
| +2% | +$78.7K |
|
58
Duolingo
DUOL
$13.6B
| $4.94M | 0.51% |
17,500
+4,432
| +34% | +$1.25M |
|
59
Hovnanian Enterprises
HOV
$827M
| $4.8M | 0.49% |
+23,500
| New | +$4.8M |
|
60
Kymera Therapeutics
KYMR
$2.95B
| $4.59M | 0.47% |
97,000
+5,000
| +5% | +$237K |
|
61
Insmed
INSM
$28.8B
| $4.53M | 0.46% |
62,000
+26,000
| +72% | +$1.9M |
|
62
Pool Corp
POOL
$11.6B
| $4.14M | 0.42% |
+11,000
| New | +$4.14M |
|
63
Canadian Pacific Kansas City
CP
$69.9B
| $3.85M | 0.39% |
+45,000
| New | +$3.85M |
|
64
Viridian Therapeutics
VRDN
$1.5B
| $3.8M | 0.39% |
+167,000
| New | +$3.8M |
|
65
Avidity Biosciences
RNA
$5.99B
| $3.4M | 0.35% |
+74,000
| New | +$3.4M |
|
66
Wingstop
WING
$9.16B
| $2.5M | 0.26% |
+6,000
| New | +$2.5M |
|
67
Transmedics
TMDX
$3.92B
| $2.43M | 0.25% |
15,500
-8,500
| -35% | -$1.33M |
|
|
VRNA
68
Verona Pharma
VRNA
$9.16B
| $2.07M | 0.21% |
+72,000
| New | +$2.07M |
|
69
Maravai LifeSciences
MRVI
$350M
| $1.99M | 0.2% |
+240,000
| New | +$1.99M |
|
70
Intellia Therapeutics
NTLA
$1.22B
| $1.89M | 0.19% |
+92,000
| New | +$1.89M |
|
|
71
Arm
ARM
$147B
| $1.43M | 0.15% |
10,000
-69,000
| -87% | -$9.87M |
|
72
Perspective Therapeutics
CATX
$250M
| $1.34M | 0.14% |
100,000
-42,499
| -30% | -$567K |
|
|
ABVX
73
Abivax
ABVX
$6.12B
| $1.31M | 0.13% |
113,631
-57,006
| -33% | -$657K |
|
74
Medical Properties Trust
MPW
$2.7B
| $1.08M | 0.11% |
+185,000
| New | +$1.08M |
|
75
e.l.f. Beauty
ELF
$7.09B
| – | – |
-40,000
| Closed | -$8.43M |
|